Daniel V. Tierney just provided an update on share ownership of Biocept

Daniel V. Tierney just filed a "Statement of acquisition of beneficial ownership", which is also known as a 13G. In the filing, it appears as though Daniel V. Tierney claims to own 1,129,321 shares. This represents 6.3% of Biocept.

Please note that typos are common in SEC filings. Please verify the information reported above before acting on it.

To receive a free e-mail notification whenever Biocept makes a similar move, sign up!

Other recent filings from the company include the following:

Biocept director was just granted 15,000 options - June 2, 2017
Biocept director was just granted 15,000 options - June 2, 2017
Biocept director was just granted 15,000 options - June 2, 2017
Biocept director was just granted 15,000 options - June 2, 2017
Biocept's CEO & President just picked up 50,000 shares - June 2, 2017

Auto Refresh

Feedback